PPARA and steatosis: Meanwhile it has been shown that, in healthy individuals, peroxisome proliferator-activated receptor alpha (PPAR-α) acts to ameliorate steatosis but, in the presence of mitochondria dysfunction—which can be seen in HCV patients—PPAR-α may exacerbate steatosis [8, 10].